In 2013, Apollo was nothing more than a concept, fueled by Founder and President, Bryan Hendin’s intense passion to clinically prove the anecdotal evidence of patients who told him cannabis worked for their pain.

The original research study goal was to enroll 100 participants.

To date Apollo has over 10,000 active patients.

Apollo owns two studies published in peer-reviewed journals on sleep and chronic pain, with a third ongoing study on PTSD, one of the largest of its kind in Canada.